Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults
Sponsor: Adam Brickman
A PHASE1 clinical study on Alzheimer Disease, this trial is completed. The trial is conducted by Adam Brickman and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE1
Status: Enrolling By Invitation → Completed
-
Nov 2022 — Oct 2023 [monthly]
Enrolling By Invitation PHASE1
▶ Show 6 earlier versions
-
Sep 2021 — Nov 2022 [monthly]
Enrolling By Invitation PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE1
Status: Recruiting → Enrolling By Invitation
-
May 2019 — Aug 2020 [monthly]
Recruiting PHASE1
-
Feb 2019 — May 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Adam Brickman
- National Institute on Aging (NIA)
For direct contact, visit the study record on ClinicalTrials.gov .